CDPI Pharma is a pioneering company in professional development for the industrial sector, offering post-graduate programs, specialized training, and technical and scientific consulting services for pharmaceutical industries. Founded in 2019, CDPI Pharma's focus is on sustainable development through education, capacity building, and project development for executives, entrepreneurs, and managers.
The company's founder, Poatã Casonato, with over 18 years of industrial experience, brings a unique entrepreneurial perspective to the business. CDPI Pharma has been at the forefront in offering specific courses on new measures by the National Health Surveillance Agency (Anvisa) and leadership training, making it a leader in the field.
CDPI Pharma's commitment to capacitating professionals is evident in its collaboration with industry-leading organizations such as ICTQ - Postgraduate for the Pharmaceutical Market and EPHAR - Industrial Analytical Laboratory. The company is recognized for its excellence and innovative educational solutions, which have set it apart in the industrial market since 2009.
CDPI Pharma is a key player in the education, healthcare, and pharmaceutical industries, aiming to facilitate the transformation of professionals within the industry. With a strong focus on quality and innovation, CDPI Pharma continues to be a noteworthy entity in the industrial education space.
There is no investment information
No recent news or press coverage available for CDPI Pharma.